Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179881
Status:
COMPLETED
Last Update Posted:
2019-02-05
First Post:
2005-09-12
Brief Title:
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Sponsor:
Ann Robert H Lurie Childrens Hospital of Chicago
Organization:
Ann Robert H Lurie Childrens Hospital of Chicago
Study Overview
Official Title:
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Treatment on this study combines two drugs Thalomid thalidomide and carboplatin Thalidomide has been available for many years and has been used to treat many different illnesses Carboplatin is an effective medicine in killing cancer cells Thalidomide works by blocking angiogenesis the process of new blood vessel formation If a tumor does not have blood vessels providing oxygen and nutrients it will not be able to grow This research will look at how combining the effects of thalidomide preventing tumor growth with the tumor killing effect of carboplatin effects the long-term outlook for patients with these tumors
This study will try to find out how well Thalomid and carboplatin combined with radiation therapy works in treating children newly diagnosed with brain stem glioma This study will look at how well Thalomid and carboplatin work in patients with recurrent brain stem glioma This study will also look at any side effects of these treatments
This study will try to find out how well Thalomid and carboplatin combined with radiation therapy works in treating children newly diagnosed with brain stem glioma This study will look at how well Thalomid and carboplatin work in patients with recurrent brain stem glioma This study will also look at any side effects of these treatments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None